Grand Challenges — Placental and Gut Inflammation Interventions for Fetal Growth
Funds global teams developing drug, biologic, dietary, or microbiome-based interventions that target placental and gut inflammatory pathways to improve fetal growth outcomes in low-income countries.
This Grand Challenge is run by the Gates Foundation under its Grand Challenges program. It funds interventions targeting the maternal gut-placenta inflammatory axis — a potential driver of fetal growth restriction (FGR) — which affects an estimated 23.4 million infants born growth-restricted each year, with 60–70% of cases in sub-Saharan Africa and South Asia. Three funding tracks cover the full i…
Drug-based, biologic, dietary, and microbiome-informed interventions targeting maternal gut-placenta inflammatory axes and oxidative stress during pregnancy. Three tracks: mechanism and target discovery (up to $400K), candidate validation and translational advancement (up to $750K), and early clinical proof-of-concept (up to $1M). Focus on global south pregnancy contexts.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up